Who owns Mural Oncology PLC?
- Ticker: MURA
- CUSIP Number: g63365103
Tip: Access positions for across all investors
Analyze quarterly positions in Mural Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mural Oncology stock
Who bought or sold Mural Oncology PLC this quarter?
There are no current stakeholders of Mural Oncology.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Mural Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 736k | $1.5M |
| Vanguard Group | Sep 2025 | 455k | $941k |
| Renaissance Technologies | Sep 2025 | 146k | $302k |
| Simplex Trading | Sep 2025 | 90k | $186k |
| State Street Corporation | Sep 2025 | 85k | $176k |
| Virtu Financial | Sep 2025 | 56k | $115k |
| Northern Trust | Sep 2025 | 33k | $69k |
| Raymond James Financial | Sep 2025 | 18k | $38k |
| XTX Topco | Sep 2025 | 11k | $22k |
| Tower Research Capital | Sep 2025 | 1.9k | $3.9k |
| Advisor Group Holdings | Sep 2025 | 1.8k | $3.7k |
| Royal Bank of Canada | Sep 2025 | 1.1k | $2.0k |
| FMR | Sep 2025 | 400.00 | $828.000000 |
| Jpmorgan Chase & Co | Sep 2025 | 232.00 | $464.000000 |